So, officially, I object. The PRESIDING OFFICER. The objection is heard. The Senator from Utah.

The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.

Mr. President, I ask for the yeas and nays, or whatever means yes and no. The PRESIDING OFFICER. Is there a sufficient second? There appears to be a sufficient second. The clerk will call the roll. The bill clerk called the roll.

Mr. President, I am here on behalf of Senator Sanders, who was pulled away from the floor on an important matter, and he asked me to object on this matter. He gave me some documentation and some points. I don't want to burden the Senate…

patients would be better off if PBMs and other supply chain entities were paid flat fees

pharmacy benefit managers are key players, or should be, in alleviating patients' financial burden at the pharmacy counter

PBMs make more money when a drug's list price increases, while patients bear the financial burden.

it would be better for patients if the supply chain was delinked from list prices

The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.

Again, I thank the chairman for his help and his support. I thank the Congressman, Dr. Andy Harris, for traveling the great distance to New Jersey to be at the hearing that we had in the field. I thank Congressman Chris Smith for his…

Mr. President, section 36(b) of the Arms Export Control Act requires that Congress receive prior notification of certain proposed arms sales as defined by that statute. Upon such notification, the Congress has 30 calendar days during which…

patients would be better off if PBMs and other supply chain entities were paid flat fees

PBMs make more money when a drug's list price increases, while patients bear the financial burden.

This level of concentration gives these PBMs market power over data, drug coverage, and contracting--80 percent.

This level of concentration gives these PBMs market power over data, drug coverage, and contracting--80 percent.

it would be better for patients if the supply chain was delinked from list prices

Mr. President, I am extremely pleased that the Senate will be voting shortly to confirm Ambassador Richard Verma to be the Deputy Secretary of State for Management and Resources at the Department of State. This role is one of the most…

pharmacy benefit managers are key players, or should be, in alleviating patients' financial burden at the pharmacy counter